Abstract

Sensitive and reliable early diagnostic markers for oral squamous cell carcinoma (OSCC) remain unavailable. Early identification of recurrence for OSCC is also a challenge. Unlike the other deep cancers, OSCC is located in oral cavity. The DNA, RNA, and protein derived from the living cancer cells and inflammatory cells then can be conveniently obtained from saliva. High-throughput genomic and proteomic approaches have been carried out to identify the potential biomarkers in body fluids such as saliva and blood for diagnosis and prognosis of OSCC. This article reviewed the recently identified biomarkers from saliva for OSCC. In addition, the biomarkers which have been correlated with OSCC tumor malignancy by molecular pathology analysis are also described. Finally, the potential biomarkers that have been demonstrated to associate with the malignant OSCC may be used for salivary screening for high-risk patients are suggested. This article may help to identify the potential biomarkers for screening and the molecular pathology analysis for high-risk patients of OSCC. Effective screening to identify high-risk patients can allow the clinician to provide the appropriate treatment without delay and to reduce the recurrence of OSCC.

Original languageEnglish
Pages (from-to)226-231
Number of pages6
JournalOral Oncology
Volume46
Issue number4
DOIs
Publication statusPublished - Apr 2010

    Fingerprint

Keywords

  • Biomarker
  • Body fluid
  • Diagnosis
  • Genomics
  • Oral squamous cell carcinoma
  • Prognosis
  • Proteomics
  • Saliva

ASJC Scopus subject areas

  • Oncology
  • Oral Surgery
  • Cancer Research

Cite this